Cytotoxic activity of crude extracts from Datura stramonium’s fungal endophytes against A549 lung carcinoma and UMG87 glioblastoma cell lines and LC-QTOF-MS/MS based metabolite profiling by Tapfuma, Kudzanai Ian et al.
RESEARCH ARTICLE Open Access
Cytotoxic activity of crude extracts from
Datura stramonium’s fungal endophytes
against A549 lung carcinoma and UMG87
glioblastoma cell lines and LC-QTOF-MS/MS
based metabolite profiling
Kudzanai Ian Tapfuma1, Nkemdinma Uche-Okereafor1, Tendani Edith Sebola1, Raeesa Hussan2, Lukhanyo Mekuto3,
Maya Mellisa Makatini4, Ezekiel Green1 and Vuyo Mavumengwana2*
Abstract
Background: Endophytic fungi are a proven source of bioactive secondary metabolites that may provide lead
compounds for novel drug discovery. In this study, crude extracts from fungal endophytes isolated from Datura
stramonium were evaluated for cytotoxic activity on two human cancer cell lines.
Methods: Fungal endophytes were isolated from surface sterilized aerial parts of D. stramonium and identified
using molecular, morphological and phylogenetic methods. Ethyl acetate crude extracts from these isolates were
evaluated for cytotoxic activity on A549 lung carcinoma and UMG87 glioblastoma cell lines. Metabolite profiling
was then performed by liquid chromatography coupled to quadrupole time-of-flight with tandem mass spectrometry
(LC-QTOF-MS/MS) for the cytotoxic crude extract.
Results: Eleven fungal endophytes were identified from D. stramonium. Significant cytotoxicity was only observed from
the crude extract of Alternaria sp. KTDL7 on UMG87 glioblastoma cells (IC50 = 21.49 μg/ml). Metabolite profiling of this
crude extract tentatively revealed the presence of the following secondary metabolites: 1,8-dihydroxynaphthalene (1),
anserinone B (2), phelligridin B (3), metacytofilin (4), phomopsidin (5) and vermixocin A (6). Compounds 2 and 3 have
been shown to be cytotoxic in literature.
Conclusion: The findings in this study suggest that the crude extract of Alternaria sp. KTDL7 possesses compound(s)
cytotoxic to glioblastoma multiforme cells. Future studies to isolate and characterize the cytotoxic compound(s) from
this fungus could result in lead development of a fungal-based drug for glioblastoma multiforme treatment.
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Background
Internal tissues of plants are habitats of a class of benefi-
cial endosymbiotic microorganisms (predominantly bac-
teria and fungi) called endophytes that have been
observed in all plants investigated to date [1]. In this
plant-endophyte relationship, plants are hosts which
generally offer nourishment and protection while endo-
phytes improve plant defense, health and stress tolerance
by solubilizing phosphates, fixing nitrogen, secreting
siderophores, hydrolytic enzymes, antimicrobials or by
producing plant hormones such as indole-3-acetic acid
[2, 3].
In comparison to free living fungi, crude extracts of
fungal endophytes are an underexplored but rich source
of bioactive and chemically diverse secondary metabo-
lites which include terpenoids, alkaloids, phenols, furan-
diones, dimeric anthrones and benzopyroanones [4, 5].
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: vuyom@sun.ac.za
2South African Medical Research Council Centre for Tuberculosis Research,
Division of Molecular Biology and Human Genetics, Department of
Biomedical Sciences, Stellenbosch University, Tygerberg 7505, South Africa
Full list of author information is available at the end of the article
Tapfuma et al. BMC Complementary and Alternative Medicine          (2019) 19:330 
https://doi.org/10.1186/s12906-019-2752-9
This is evidenced by a detailed review of 46 genera and
111 species of fungal endophytes producing cytotoxic
secondary metabolites by Chen et al. [6]. In order to in-
crease the likelihood of isolating fungal endophytes that
produce medicinally important secondary metabolites,
documented medicinal plants that are used in traditional
medicine are targeted [5].
Datura stramonium is a medicinal plant that is known
for producing over 64 tropane alkaloids of which atropine,
scopolamine and hyoscyamine are predominantly found
in relatively high concentrations [7, 8]. While ethnomedi-
cal uses of D. stramonium include inhalation of smoke
from burnt leaves to relieve symptoms of asthma, bron-
chitis, sedation, epilepsy and psychosis to name just a few
[8], exploration into the use of tropane alkaloids as poten-
tially anticancer lead compounds has been ongoing since
the early 2000s [9]. Bacterial and fungal endophytes have
been previously isolated from D. stramonium in studies
focusing on the potential use of endophytic extracts as
biocontrol agents for controlling plant and human patho-
gens [10–13], in vitro α-glucosidase inhibitors and antioxi-
dant agents [14]. To the best of our knowledge, this is the
first study that reports the cytotoxic activity of crude ex-
tracts endophytic fungi from D. stramonium on human
A549 lung carcinoma and UMG87 glioblastoma cell lines.
The results of the bioactive crude extract observed in this
study may form a foundation for developing a fungal-
derived drug for glioblastoma multiforme treatment.
Methods
Collection of plant material
Healthy free growing D. stramonium plants were col-
lected in summer in Johannesburg (South Africa) at the
following coordinates: 26°13′04.5″S, 28°12′48.3″E. Plant
diversity and vegetative growth on the site were high
with different species interspersed between D. stramo-
nium. Plant samples were transferred to the laboratory
immediately after collection and were thoroughly
washed with distilled water upon arrival. Formal identifi-
cation of the collected plants was done by Abdulwakeel
Ayokun-nun Ajao, a botanist from the Department of
Botany and Plant Biotechnology at the University of Jo-
hannesburg. A voucher specimen of the whole plant was
deposited in the department’s public herbarium and was
assigned deposition number RAM-001.
Isolation and morphological characterization of fungal
endophytes
The isolation of fungal endophytes was done on the
same day of collection following a modified method de-
scribed by Uche-Okereafor et al., [15]. Briefly, 10 g of
each of the aerial plant parts (stems, leaves, fruit covers
and seeds) were separately soaked in 5% Tween 80, ad-
equate to cover each sample for five minutes with
vigorous shaking. This was subsequently followed by
washing the samples several times with sterile distilled
water to remove Tween 80. Samples were then dipped
in 70% ethanol for 1 min and rinsed with sterile distilled
water five times, followed by dipping in 1% sodium
hypochlorite for 10 min. Plant parts were then finally
rinsed five times with sterile distilled water and aliquots
of 50 μL of the last rinse water for each sample were
plated on potato dextrose agar (PDA) (Merck, Johannes-
burg, SA) as wash controls to determine the effective-
ness of surface sterilization. The surface sterilized
samples were then macerated in sterile phosphate buff-
ered saline (PBS) (Oxoid, Basingstoke, Hampshire, UK)
solution using a sterile mortar and pestle. Serial dilutions
of macerated samples were made by pipetting 1mL of
macerated sample into 9 mL of PBS to make a 10− 1 dilu-
tion, followed by subsequent dilutions up to 10− 9. The
serial dilutions were then plated in triplicates on PDA
for enumeration of fungal endophytes and incubated at
28 °C (IncoTherm, Labotec, Johannesburg, SA) for up to
21 days. Morphologically distinct fungal isolates were
then sub-cultured several times to obtain pure isolates.
Fungi were differentiated from bacteria using lactophe-
nol cotton blue staining. Lactophenol cotton blue is a
dye which stains chitin in fungal cell walls blue [16].
Molecular characterization (rDNA-ITS sequencing and
phylogenetic analysis)
DNA extraction was done using the ZR Fungal/Bacterial
DNA Kit™ (Zymo Research, Irvine, CA, USA), following
the manufacturer’s instructions. Polymerase chain reac-
tion (PCR) was done to amplify the internal transcribed
spacer (ITS) region of ribosomal DNA (rDNA) using the
ITS1 (5´-TCCGTAGGTGAACCTGCGG-3´) and ITS4
(5´-TCCTCCGCTTATTGATATGC-3´) primer pair. For-
ward and reverse direction sequencing was done using the
ABI PRISM™ 3500xl Genetic Analyzer (Thermo Fisher
Scientific, Inc., Waltham, MA, USA) followed by the puri-
fication of the sequencing products using ZR-96 DNA Se-
quencing Clean-up Kit™ (Zymo Research, Irvine, CA,
USA). DNA sequences were then analyzed using the
FinchTV software [17], followed by a Nucleotide Basic
Local Alignment Search (BLASTN) on the National Cen-
ter for Biotechnology Information (NCBI) using the Gen-
Bank database to identify closely matching organisms [18].
The sequences used in the molecular data sets ranged
from 450 to 700 base pairs prior to deletion of ambiguous
data occurring at the beginning or at the end of each se-
quence [19]. Maximum likelihood phylogenetic recon-
struction was done using MEGA version 7.0 software [20],
with Dothidea insculpta and Monochaetia monochaeta as
outgroups. Bootstrap values were calculated from 1000
replicate runs. Phylogenetic reconstruction of isolates was
done by grouping isolates according to morphological
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characteristics observed on PDA cultures. The rDNA-ITS
sequences were then submitted to GenBank.
Shannon-Weiner diversity index (H´)
Fungal endophyte diversity was determined by the
Shannon-Wiener diversity index (H´), using the formu-
lae below:
HËC ¼ Σ Pi ln Pið Þ; Pi ¼ mi
N :
where mi represents number of individuals and N rep-
resents the total number of individuals [21].
Fermentation and extraction of secondary metabolites
Fungal endophytes were fermented as monocultures in
3 L of PDB (Potato infusion 200 g/L, dextrose 20 g/L)
[22]. Incubation was done for 21 days at 28 °C in an or-
bital shaking incubator (Amerex Gyromax, Temecula,
CA, USA) at 150 rpm. After fermenting the fungi, extro-
lites which are mainly secondary metabolites were ex-
tracted from broth monocultures using analytical grade
ethyl acetate [23]. This extraction was achieved by firstly
filtering the broth monocultures through a Whatman
No. 1 filter paper to separate the mycelia from the broth
culture. Equal volumes of ethyl acetate and filtrate broth
were then added to a separating funnel, shook vigorously
to mix the two liquids and allowed to stand for 20 min.
The organic solvent phase was then collected and con-
centrated using a rotary evaporator under reduced pres-
sure at 40 °C and the resulting crude extracts were
allowed to air dry and consequently stored at − 20 °C.
MTS assay on UMG87 glioblastoma and A549 lung
carcinoma cell lines
End-point cytotoxicity evaluation of crude extracts on
UMG87 glioblastoma and A549 lung carcinoma cell
lines (ATCC, Manassas, VA, USA) was performed fol-
lowing the colorimetric MTS [3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium] assay method [6, 10]. Cells at 5 × 104 cells/
mL were initially seeded in 96 well plates containing
Dulbecco’s modified eagle medium (Gibco, Carlsbad,
CA, USA) with 15% heat inactivated fetal bovine serum
(Merck, Johannesburg, SA) and incubated at 37 °C in 5%
CO2 (v/v) for 24 h [24]. Crude fungal extracts and aura-
nofin (a positive control) were then dissolved in di-
methyl sulfoxide (DMSO) (Merck, Johannesburg, SA)
and then added to cell cultures at concentrations of
3.13, 6.25, 12.5, 25, 50 and 100 μg/mL, in triplicates. The
cell cultures were then left to incubate for a further 96 h,
after which 5 μl of MTS (Promega, Madison, WI, USA)
was added to the cells and absorbance values measured
at 490 nm after 1, 2 and 4-h incubation periods. Cell via-
bility was calculated using the following formulae:
%Cell Viability ¼ Ea−Ba
Ca−Ba
 100
where Ea is absorbance of the extract, Ba is absorbance
of the blank and Ca is the absorbance of the negative
control (untreated cells) [25]. GraphPad Prism software
(v. 7.05, GraphPad Software, Inc., La Jolla, CA, USA)
was used to produce dose response curves by non-linear
regression analysis of cell viability data, hence determin-
ing the mean inhibitory concentration (IC50) value.
xCELLigence® real-time cell analyzer (RTCA) assay on
U87MG glioblastoma cells
xCELLigence® RTCA assay was performed by initially
seeding 1 × 105 cells/mL of U87MG glioblastoma cells on
gold microelectrode precoated 96 well electronic plates
(E-Plate® 96, ACEA Biosciences Inc., San Diego, CA, USA)
and incubating at 37 °C in 5% CO2 (v/v) for 45 h. Selected
crude fungal extracts and auranofin (a positive control)
were then dissolved in DMSO and then added at concen-
trations of 3.13, 6.25, 12.5, 25, 50 and 100 μg/mL, in tripli-
cates. Untreated cells (0 μg/mL) were included as a
negative control. The cell cultures were then incubated
for a further 171 h, with impedance measurements taken
every 15min during the total incubation period of 216 h.
The data was retrieved, and a graphic representation of
the bioactivity was reproduced.
Metabolite profiling of fungal crude extracts by LC-QTOF-
MS/MS
Metabolite profiling of the cytotoxic fungal extract was
done by liquid chromatography coupled to a quadrupole
time-of-flight with tandem mass spectrometry (LC-
QTOF-MS/MS), using a previously described modified
method [26, 27]. This system has a Dionex UltiMate 3000
ultra-high-performance liquid chromatography (UHPLC)
(Thermo Scientific, Darmstadt, Germany) coupled to a
Compact™ QTOF (Bruker Daltonics, Bremen, Germany)
that uses an electrospray ionization (ESI) interface. The
crude extract of the fungal endophyte Alternaria sp.
KTDL7 was prepared for analysis by dissolving 1mg/mL
(w/v) in HPLC grade methanol (Merck, Johannesburg,
SA), followed by sonication for 10min, and finally filtra-
tion through 0.22 μm polyvinylidene fluoride (PVDF)
membrane syringe filters into 1mL LC auto-sampler vials.
An injection volume of 5 μL was used in the system for
chromatographic separation of analytes in reverse phase
ultra-high-performance liquid chromatography (RP-
UHPLC) through a Raptor ARC-18 column with dimen-
sions of 2.7 μm (particle size), 2.1 mm (internal diameter),
100mm (length) and 90 Å (pore size) (Restek, Bellefonte,
PA, USA). The mobile phase was composed of solvent A
(A) consisting of 0.1% formic acid in H2O (v/v) and solv-
ent B (B) consisting of 0.1% formic acid in acetonitrile (v/
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v). Gradient flow of the mobile phase was initiated by a
2.0 min isocratic step at 5% B followed by an increase to
95% in 28min, an isocratic step at 95% B for 5min
followed by a decrease to 5% B in 1min upon re-
equilibration to initial conditions at a flow rate of 300 μL/
min. The ESI(+) parameters were as follows: set capillary
voltage at 4.5 kV; end plate offset at − 500 V; dry heater
temperature at 220 °C; dry gas flow rate at 2.5 L/min and
nebulizer gas pressure at 1.8 Bar. Mass spectra were ac-
quired in centroid mode ranging from 50 to 1300m/z
[28]. Instrument operation, control and data acquisition
was done using HyStar software version 2.10 (Thermo Sci-
entific, Darmstadt, Germany). Spectral data processing
was performed in Bruker Compass DataAnalysis software
version 4.3 (Bruker Daltonics, Bremen, Germany). Met-
Frag web tool version 2.1 (https://msbi.ipb-halle.de/Met-
FragBeta/) was used to characterize the resulting fragment
spectra by linking to three compound databases, namely
PubChem, ChemSpider and KEGG [29]. The MetFrag
settings used were as follows: The MetFrag database
search settings used were as follows: Database search
relative mass deviation (Search ppm) = 10.0; precursor
ion = [M +H]+; fragment peak match absolute mass
deviation (Mzabs) = 0.01; fragment peak match relative
mass deviation (Mzppm) = 10; charge = positive and
mode = [M +H]+.
Statistical analysis
Quantitative variables were analyzed in STATISTICA
version 10 (StatSoft, Inc., Tulsa, OK, USA). Multivariate
analysis of variance (MANOVA) and the least significant
difference (LSD) post hoc were used to analyze the
mean ± standard deviation (SD) of crude extracts at vari-
ous concentrations. A probability of P ≤ 0.05 was taken
to indicate statistical significance.
Results
Isolation, characterization and identification of culturable
fungal endophytes
In this study, 11 culturable fungal endophytes were re-
covered from D. stramonium (seven isolates from the
leaves, three from the stems and one from the seeds).
Examination of morphological macroscopic and micro-
scopic features revealed that four out of eleven were fila-
mentous fungi. Analysis of the ITS sequences resulted in
the taxonomic classification of five fungal isolates to spe-
cies level with the rest only classified to genus level
(Table 1). These results corroborated with the phylogen-
etic reconstruction which grouped isolates according
their respective genera and species (see Additional file 1).
The Shannon-Weiner diversity index (H´) for the iso-
lated endophytes was calculated and found to be 3.44
with the highest diversity observed in isolates from the
leaves. This diversity index takes into account
homogeneity/heterogeneity of isolates and usually ranges
between 1.5 to 4.5, where the higher values correspond
to increase in species diversity [30].
MTS cytotoxicity assay on A549 lung carcinoma cells
Statistically significant differences in the effect of fungal
crude extracts on A549 lung carcinoma cells were ob-
served at P ≤ 0.05 level even though the cytotoxicity ob-
served was limited. Cell viability ranged from 92.2 to
146.9%, reflecting limited inhibitory effect presented by
the fungal crude extracts during the incubation period
of 96 h (Fig. 1). Cell viability of above 100% was mostly
observed for the highest concentrations of fungal crude
extracts (25, 50 and 100 μg/mL), which may typically
have resulted from the antioxidant potential of com-
pounds in fungal crude extracts, causing elevated ab-
sorbance values for the reduced of MTS product
(formazan) that are higher than those observed in the
negative control cells [31, 32].
MTS cytotoxicity assay on UMG87 glioblastoma cells
The crude fungal extract from Alternaria sp. KTDL7
showed the highest antiproliferative activity on UMG87
glioblastoma cells, recording the lowest cell viability of
2.68% at 50 μg/mL, followed by 4.29% at 100 μg/mL (Fig.
1). Multi-variate analysis of variance test of the means
from the two concentrations showed that their cytotoxic
activity had no significant difference since P > 0.05. Fur-
thermore, the cytotoxic effects of these two concentrations
from Alternaria sp. KTDL3 were found to be comparable
with that of auranofin on the same cell line at treatments
of 12.5–100 μg/mL (Fig. 1). The IC50 value for the fungal
extract from Alternaria sp. KTDL7 was determined by
plotting a dose-response curve (Fig. 2) and was found to
be 21.49 μg/mL, just below the American National Cancer
Institute guidelines (NIC) for preliminary screening assays
which state that crude extracts achieving 50% anti-
proliferative activity at < 30 μg/mL after 72 h of exposure
are to be regarded as cytotoxic [33, 34].
xCELLigence® RTCA assay on UMG87 glioblastoma cells
UMG87 glioblastoma cells were exposed to selected fun-
gal crude extracts of A. alternata KTDL3, Bipolaris sp.
KTDS5 and Alternaria sp. KTDL7 which was initially
observed to induce cytotoxicity on this cell line. Re-
sponse of the cells to the fungal extracts was monitored
for 171 h using a RTCA system. A dose-dependent in-
hibition was observed for the crude extract of Alternaria
sp. KTDL7, where the highest concentration of 100 μg/
mL induced an irreversible cytotoxic effect on the
UMG87 glioblastoma cells as shown in Fig. 3. Cells ex-
posed to 100 μg/mL of the crude extract were unable
show significant recovery from the cytotoxic effects from
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Table 1 Eleven fungal endophytes isolated from D. stramonium
Fungal
isolate
Accession
number
Closest relatives in NCBI ITS identity
(%)
Tissue Phylum; Class; Order Classification
KTDL1 MF952612 Gyroporus castaneus Gc1 (EU718099) 88 Leaves Basidiomycota; Agaricomycetes;
Boletales
Gyroporus sp.
KTDL2 MF952613 Alternaria tenuissima Isolate 4
(KU937315)
97 Leaves Ascomycota; Dothideomycetes;
Pleosporales
A. tenuissima
KTDL3 MF952614 A. alternata CS36–4 (KY814634) 100 Leaves Ascomycota; Dothideomycetes;
Pleosporales
A. alternata
KTDL4 MF952615 Colletotrichum sp. LTL119 (MF663557) 100 Leaves Ascomycota; Sordariomycetes;
Glomerellales
Colletotrichum sp.
KTDL6 MF952616 Talaromyces sp. SWP-2017 k NRRL
62271 (KX657354)
89 Leaves Ascomycota; Eurotiomycetes;
Eurotiales
Talaromyces sp.
KTDL7 MF952617 Alternaria sp. XN-3-1 (KR822138) 100 Leaves Ascomycota; Dothideomycetes;
Pleosporales
Alternaria sp.
KTDL8 MF952618 Sporothrix schenckii CBS 211.61
(KP017093)
100 Leaves Ascomycota; Sordariomycetes;
Ophiostomatales
Sporothrix schenckii
KTDL11 MF952619 Trichoderma longibrachiatum FIB PRI 6.2
(LC106115)
91 Seeds Ascomycota; Sordariomycetes;
Hypocreales
Trichoderma sp.
KTDS1 MF952620 Pilobolus crystallinus 007pNNP
(KP760865)
98 Stem Zygomycota; Mucoromycotina;
Mucorales
Pilobolus
crystallinus
KTDS2 MF952621 Rhodotorula mucilaginosa Feni 103
(KP223714)
99 Stem Basidiomycota; Urediniomycetes;
Sporidiales
Rhodotorula
mucilaginosa
KTDS5 MF952622 Bipolaris setariae GP14 (KR183790) 99 Stem Ascomycota; Dothideomycetes;
Pleosporales
Bipolaris sp.
Fig. 1 A summative profile of bioactivity activity of fungal extracts on (a) A549 lung carcinoma cells and (b) UMG87 glioblastoma cells after 96 h
of exposure. Columns in the histograms represent the mean ± SD (n = 3) of fungal crude extracts tested at six different concentrations ranging
from 3.13 to 100 μg/mL. The positive control was auranofin and the alphabets above the columns represent significant differences among various
concentrations of extracts
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the point of exposure at the 45th hour to the 216th hour
on the timeline.
Auranofin (a positive control) had a striking effect on
UMG87 glioblastoma cells as some concentrations
seemed to promote hyper metabolism than inhibit it. Ex-
posure of the cells to a drug concentration of 6.25 μg/mL
at the 45th hour resulted in an immediate decline in cell
viability followed by a recovery and surge in viability from
the 96th hour which exceeded the cell viability of the
negative control (0 μg/mL) and cells treated with 3.13 μg/
mL of the drug. The surge in viability of cells treated with
6.25 μg/mL of auranofin at the 96th hour could be associ-
ated with development of antineoplastic resistance of sur-
viving cells, leading them to overcome the cytotoxic
effects of auranofin by upregulation of metabolic genes
and thus leading to a spike in cell viability. Mechanisms of
drug resistance in glioblastoma cells have been reviewed
in Haar et al., [35]. Similar to the MTS assay, no signifi-
cant cytotoxic activity was observed for the crude extracts
of A. alternata KTDL3 and Bipolaris sp. KTDS5.
Metabolite profiling of Alternaria sp. KTDL7’s crude
extract by LC-QTOF-MS/MS
Secondary metabolites in the crude extract of Alternaria
sp. KTDL7 were tentatively identified using an untar-
geted screening method. The impact of PDB on the fun-
gal crude extract was considered by analyzing the
spectrum of PDB and subtracting it from the spectrum
of the fungal crude extract. Secondary metabolites were
identified using the spectral information of molecular
ions and their collision induced dissociation (CID) frag-
ments which were compared with reference compounds
and their in-silico fragments in online databases (Fig. 4)
[36]. The identified compounds are as follows: 1,8-dihy-
droxynaphthalene (1), anserinone B (2), phelligridin B
(3), metacytofilin (4), phomopsidin (5) and vermixocin
A (6). CID mass fragment data is available in
Additional file 2.
Discussion
Medicinal plants with known ethnopharmacological
properties are proven sources for isolation of endophytes
that produce secondary metabolites with novel and med-
ically significant bioactivities [21, 37]. The surface
sterilization method of isolating endophytes is highly ef-
fective to reduce contamination of epiphytes when so-
dium hypochlorite is employed [38]. In this study,
efficacy of surface sterilization was validated by plating
on PDA the last rinse water used in the surface
sterilization process as a control. No microbial growth
was observed on these plates.
The Shannon-Wiener diversity index (H´) for the iso-
lated endophytes was calculated and found to be 3.44,
indicating a high species diversity among the fungal
endophyte community in D. stramonium. Greatest diver-
sity was observed in the leaves where the highest num-
ber of isolates were recovered with the Alternaria genus
being the most prevalent. This genus has been previ-
ously reported as an endophyte in D. stramonium [39],
while also being a pathogen in other plants of a different
species which include cereals, strawberries and tomatoes
[40]. Interestingly, pathotypes of the Alternaria genus
mostly occur as foliar pathogens which produce host-
selective toxins (HSTs) to target the above-mentioned
susceptible plants [41]. Both the endophytes and patho-
types of this genus are rarely isolated from the seeds and
roots, and less frequently from the stems [40–43].
The three endophytes from the Alternaria genus (A.
tenuissima KTDL2, A. alternata KTDL3 and Alternaria
sp. KTDL7) produced varying shades of dark brown
Fig. 2 Dose-response inhibition curve of the crude extract of Alternaria sp. KTDL7 on UMG87 glioblastoma cells
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Fig. 3 Real-time analysis of the bioactivity of crude fungal extracts on UMG87 glioblastoma cells. Extracts from Alternaria alternata KTDL3 (a), Alternaria
sp. KTDL7 (b), and Bipolaris sp. KTDS5 (c) were administered in six concentrations ranging from 0 to 100 μg/mL on the 45th hour on the timeline and
the response of the cells was monitored up until the 216th hour. Cell viability was recorded as cell index, which is a relative change in measured
impedance. Auranofin (d) was used as a positive control
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pigmented hyphae due to melanin production, a pigment
known to improve stress tolerance of plant hosts by
trapping and eliminating oxygen radicals generated dur-
ing abiotic stress [44]. The endophyte Bipolaris sp.
KTDS5 appeared to have a mixture of black pigmented
and nonpigmented white colonies, where the black pig-
ment was also evidence of fungal melanin production
[45]. Endophytes that produce melanized septate hyphae
and microsclerotia-like structures are commonly known
as “Dark Septate Endophytes” (DSE), they are collectively
thought to improve nutrient acquisition and stress toler-
ance in plants [46]. R. mucilaginosa KTDS2 had pink
colonies and G. castaneus KTDL1, Colletotrichum sp.
KTDL4, Talaromyces sp. KTDL6, S. schenckii KTDL8,
Trichoderma sp. KTDL11 and P. crystallinus KTDS1 all
had a cream-white appearance. Pigments in fungi are
chiefly produced in the mevalonate pathway and include
carotenoids such as lycopene, γ-carotene, β-carotene,
cantaxanthin, astaxanthin, neurosporaxanthin and toru-
lene [47]. Besides contributing to the metabolism of the
host plant, natural pigments produced by (endophytic)
fungi have great potential in the food and beverage in-
dustry where synthetic pigments are often toxic and car-
cinogenic [48]. The specific individual roles played by
each fungal isolate in the plant-endophyte relationship
with D. stramonium are still yet to be better understood.
Among the isolated fungal endophytes in this study,
significant and selective cytotoxic activity was observed
from the crude extract of Alternaria sp. KTDL7 on
UMG87 glioblastoma cells in the MTS assay. The high-
est cytotoxic activity of this crude extract was observed
at 50 and 100 μg/mL, indicating a dose-response
dependent activity. Still on the same fungal extract and
cell line, an interesting observation was noted whereby
the actual cell viability of the 50 μg/mL treatment
(2.68%) was found to be 1.61% lower than that of double
the concentration, the 100 μg/mL (4.29%) treatment
(Fig. 1). Upon testing the two means with multivariate
analysis of variance, no significant statistical difference
in their activity was found as the p-value P > 0.05. Mech-
anisms underlying the selective cytotoxicity observed
from the crude extract of Alternaria sp. KTDL7 were
not investigated as this was beyond the scope of this
study.
In the xCELLigence assay, the cytotoxic activity of the
crude extract of Alternaria sp. KTDL7 at 100 μg/mL on
UMG87 glioblastoma cells was observed to be much
higher and not comparable to that of the same extract at
50 μg/mL (Fig. 3). The resulting differences in the behav-
ior of this extract when assayed in the xCELLigence and
MTS assay can be explained by the fact that both assays
target different markers. The xCELLigence assay deter-
mines cell viability indirectly by measuring impedance in
96 well plates, thus cells adhered to the bottom of the
wells with micro-electrodes will increase electrical resist-
ance which is recorded as a high cell index. Detachment
of cells from the bottom of the plate will result lower
electrical resistance, hence lower cell index values. The
Fig. 4 The base peak chromatogram (bpc) of Alternaria sp. KTDL7’s crude extract and the extracted ion chromatogram (EIC) of identified secondary
metabolites which are: 1,8-dihydroxynaphthalene (1), anserinone B (2), phelligridin B (3), metacytofilin (4), phomopsidin (5) and vermixocin A (6). Meas.
m/z denotes measured m/z, while Calc. m/z denotes calculated m/z
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MTS assay targets the activity of mitochondrial activity
of living cells.
Auranofin was used in this study as a positive con-
trol in both the MTS and xCELLigence assays. Ori-
ginally, this drug was approved for the treatment of
rheumatoid arthritis. Continued studies however have
shown that auranofin (in its individual and combin-
ation treatments with other agents) exhibits antican-
cer activity by inhibiting thioredoxin reductase [49],
and thus inducing apoptosis, among other anticancer
mechanisms. A number of cancer cell lines that have
shown susceptibility to auranofin include MCF-7 hu-
man breast cancer cells [50, 51], Hep3B human hepa-
tocellular carcinoma cells [52], LNcap and 22RV1
human prostate cancer cells [53], SKOV3 ovarian can-
cer cells [54], HCT116 and HT-29 colorectal cancer
cells [55], human glioblastoma multiforme cells [56],
and 10 non-small lung cancer cell lines [57]. The
cytotoxic mechanism of action of auranofin on
UMG87 glioblastoma cells is still yet to be fully ex-
plained, however its xCELLigence profile in this study
lead to the assumption that it has an intracellular tar-
get, most likely a gene involved in metabolism since
low doses of the drug induced resistance and hyper-
metabolism (Fig. 3).
Considering the gap in knowledge about bioactive ex-
tracts from endophytic fungi, it became necessary to per-
form secondary metabolite profiling of the cytotoxic
Alternaria sp. KTDL7’s crude extract. After analyzing LC-
QTOF-MS/MS spectrum data for Alternaria sp. KDTL7’s
crude extract for previously characterized compounds,
seven secondary metabolites (Compounds 1 to 6) were
identified from compound libraries.
Compound 1 (1,8-dihydroxynaphthalene) is a key
intermediate in the synthesis of dihydroxynaphtalene
(DHN)-melanin, commonly found in fungi and is syn-
thesized via the polyketide pathway [58]. Fungi within
the Alternaria genus studied up to date have been
shown to be DHN-melanin producers, including A.
alternata 15A [59], and A. infectoria CBS 137.90 [60].
DHN-melanin was tested for antifungal activity on clin-
ical isolates and was found to have a half-minimum in-
hibitory concentration (MIC50) of 128 μg/mL for
Aspergillus flavus, 64 μg/mL for A. niger, 256 μg/mL for
A. fumigatus and 512 μg/mL for A. tamarii [61].
Compound 2 (anserinone) is a polyketide that has
been previously isolated from the cophrophilous Podos-
pora anserine, where it was found to reduce radial
growth of Sordaria fimicola and Ascobolus furfuraceus
by 50 and 37% respectively [62, 63]. In that same study,
anserinone B was found to be moderately cytotoxic with
an average IC50 of 4.4 μg/mL after being tested on the
National Cancer Institute’s 60 human tumor cell line
panel [62, 64].
Compound 3 (phelligridin B) is a styrylpyrone deriva-
tive which is synthesized within the shikimate and acet-
ate pathways [65]. This secondary metabolite has been
found in ethanolic extracts of Phellinus linteus (Sang
Huang) and has been shown to exhibit cytotoxic activity
against Bel-7402 cells at an IC50 of 0.050 μM [66].
Compound 4 (metacytofilin) has been previously iden-
tified from the culture filtrate of Metarhizium sp.
TA2759 and possess immunosuppressive properties [67].
It is a two-residue depsipeptide synthesized by non-
ribosomal peptide synthases in combination with polyke-
tide synthase [68].
Compound 5 (phomopsidin) is an interesting polyke-
tide which has been previously isolated from a marine
derived Phomopsis sp. TUF95F47 [69]. This secondary
metabolite showed inhibition of microtubule assembly at
an IC50 of 5.7 μM in the in vitro assembly analysis of
porcine brain tubulin assay [70, 71].
Compound 6 (vermixocin) is a diphenyl ether deriva-
tive, previously isolated from a marine fungus, Talaro-
myces sp. LF458 [71]. Vermixocins were previously
found to inhibit RNA synthesis as they interfered with
incorporation of labeled uridine in a murine P388
leukemia cell line [72].
Commonly known secondary metabolites which have
been previously identified in extracts of fungi from the
Alternaria genus include alternariol, alternariol mono-
methyl ether, tentoxin, altesertin, alteichin, stemphyl-
toxin, altersolanol, altenusin and tenuazenoic acid were
not detected in this study [73]. A possible explanation
for this occurrence is that different fungal strains in the
same genus have the biosynthetic capability of producing
a wide variety of chemically diverse secondary metabo-
lites [74]. The type of method and solvent used in the
extraction process may also significantly affect the na-
ture and quantity of secondary metabolites recovered
[75]. Some researchers have reported the use of acidified
extracting organic solvents or acidified filtrate broth to
increase the solubility of fungal secondary metabolites in
organic solvents [76].
Conclusions
This study provides evidence that the ethyl acetate crude
extract of Alternaria sp. KTDL7 exerts a notable dose-
dependent and selective cytotoxic activity on UMG87
glioblastoma cells. Metabolite profiling also showed that
Alternaria sp. KTDL7 is capable of producing com-
pounds similar to those from terrestrial plants and mar-
ine fungi belonging to different genera, as is the case
with compounds 2 to 6. This further supports the notion
that more complex chemical structural scaffolds with in-
teresting bioactivities are likely to be harbored by fungal
symbionts from diverse origins. Further studies will be
aimed at isolating and characterizing the cytotoxic pure
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compounds from the crude extract of Alternaria sp.
KTDL7 and determining their mechanism of action,
which could result in the development of a fungal-based
drug for glioblastoma multiforme treatment.
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